1-4 of 4
Julia Romani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition Of PI3K/mTOR Overcomes Nilotinib Resistance In BCR-ABL1 Positive Leukemia Cells

Jie Ding, PhD, Julia Romani, Margarete Zaborski, Roderick AF MacLeod, PhD, Stefan Nagel, PhD, Hans G. Drexler, MD, PhD, Hilmar Quentmeier, PhD
Journal: Blood
Blood (2013) 122 (21): 4906.
https://doi.org/10.1182/blood.V122.21.4906.4906
Published: 2013
Journal Articles

CRLF2 and JAK2 Mutations: Occurrence and Function In Pre-B ALL Cell Lines

Hilmar Quentmeier, PhD, Sonja Eberth, PhD, Roderick AF MacLeod, PhD, Stefan Nagel, PhD, Julia Romani, Margarete Zaborski, Hans G. Drexler, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 5109.
https://doi.org/10.1182/blood.V116.21.5109.5109
Published: 2010
Journal Articles

Induction of Apoptosis In Imatinib-Resistant BCR-ABL1 -Positive Leukemia Cell Lines by Bortezomib

Hilmar Quentmeier, PhD, Sonja Eberth, PhD, Julia Romani, Margarete Zaborski, Hans G. Drexler, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4469.
https://doi.org/10.1182/blood.V116.21.4469.4469
Published: 2010
Journal Articles

Hypermethylation of CD44 Is Characteristic of Specific Lymphoma Subtypes.

Sonja Röhrs, Julia Romani, Margarete Zaborski, Andreas Rosenwald, Hans G. Drexler, Hilmar Quentmeier
Journal: Blood
Blood (2009) 114 (22): 3469.
https://doi.org/10.1182/blood.V114.22.3469.3469
Published: 2009